Eye Banking



Jhanji V, Pollock GA, Mackey AL, Beltz J, Vajpayee RB. Histopathological evaluation of anterior lamellar corneal tissue-on/-off storage conditions on DSAEK donor tissue after storage in organ culture. Curr Eye Res. 2012 Feb;37(2):155-8.

Neil DA, Pollock GA, Molyneux GS, Hardie IR. Vascular changes following hypothermic preservation. Transplant Proc. 1989 Feb;21(1 Pt
2):1389-90. PMID: 2711441.

Pollock GA, Pegg DE, Hardie IR. An isolated perfused rat mesentery model for direct observation of the vasculature during
cryopreservation. Cryobiology. 1986 Dec;23(6):500-11.

Weinel L, Golding-holbrook T, Chen J Richard M. Corneal Donor Characteristics and Descemet Membrane Endothelial Keratoplasty Success: A
Scoping Review. Cornea 2021; 40(7): 930-935.

Kim BZ, Meyer JJ, Brookes NH, Moffatt SL, Twohill HC, Pendergrast DG, Sherwin T, McGhee CHJ. (2017). New Zealand trends in corneal
transplantation over the 25 years 1991 to 2015. British Journal of Ophthalmology. 101:834-838. doi:10.1136/bjophthalmol-2016-309021

Cunningham WJ, Moffatt L, Brookes NH, Twohill H, Pendergrast D, Stewart JM and McGhee CNJ. (2012). The New Zealand National Eye Bank Study: Trends in the acquisition and storage of corneal tissue over the decade 2000-2009. Cornea. 31(5):538-45. doi: 10.1097/ico.0b013e318222c3f2

Cunningham WJ, Brookes NH, Twohill HC, Moffatt SL, Pendergrast DGC, Stewart JM, McGhee CNJ. (2012). Trends in the distribution of
donor corneal tissue and indications for corneal transplantation: the New Zealand National Eye Bank Study 2000-2009. Clinical and Experimental Ophthalmology 40(2):141-7. doi: 10.1111/j.1442-9071.2011.02681.x

Patel HY, Ormonde S, Brookes NH, Moffatt L, Sherwin T, Pendergrast D and McGhee CNJ. (2011). The New Zealand National Eye Bank:
Survival and visual outcome one year following corneal transplantation. Cornea. 30(7):760-4. doi: 10.1097/ico.0b013e3182014668

Patel HY, Brookes NH, Moffatt L, Sherwin T, Ormonde S, McGhee CNJ. (2005). The New Zealand National Eye Bank Study 1991-2003: A Review of the Source and Management of Corneal Tissue. Cornea. 24(5):576-82, 2005.
doi: 10.1097/01.ico.0000155035.55751.b2

Baird P, Machin H, Brown K. Corneal supply and the use of technology to reduce its demand: A review. Clin Exp Ophthalmol. 2021 (epub
ahead of print).

Keane MC, Lowe MT, Coster DJ, Pollock GA, Williams KA. The influence of Australian eye banking practices on corneal graft survival. Med J
Aust. 2013 Aug 19;199(4):275-9.

Machin H, Arslan J, Baird P. Examining the Impact of Corneal Tissue Transnational Activity, and Transplantation, on Import and Export
Nations: A Review of the Literature. Cornea 2020; 39(6): 795-800.

Machin H, Brown K, Sutton G, Baird P. Ocular Tissue for Research in Australia: Strategies for Potential Research Utility of Surplus and
Transplant-Ineligible Deceased Donations. Transl Vis Sci Technol 2020; 9(5):4.

Machin H, Buckland L, Critchley C et al. Determining the willingness of Australians to export their corneas on death. 2021; 16(2).

Machin H, Buckland L, Georges P et al. Supply and Demand of Domestic Corneal Tissue and Its Implications on Export Potential-Using
Australia as an Example. Cornea 2021; 40(10): 1229-1235.

Machin H, Philippy B, Ross C, Sutton G, Baird PN. Part One: Understanding the impact of COVID-19 on corneal transplant need and demand
through the example of Australia. Int J Eye Bank. 2020;8(2).

Machin H, Sutton G, Baird P. Do Eye Bank Models and Competitive Practice Affect International Cornea Allocation? 2021; 40(7):

Machin H, Sutton G, Baird P. Examining Corneal Tissue Exportation Fee and Its Impact on Equitable Allocation. 2021 issue – doi:

Machin H, Sutton G, Baird P. Should Donors Consent to Export Their Corneas? Examination of Eye Tissue and Eye Care Sector Opinion 2021;
40(3): 398-403.

Machin H, Sutton G, Baird P. Should Nations With Surplus Donated Corneal Tissue Export to Those Without? A Review of Sector Opinion
Through the Example of One Nation-Australia. Cornea 2020; 39(10): 1334-1340.

Machin H, Philippy B, Pollock GA. Do Corneal Tissue Providers Inform Their Community That They Export Corneas? An Audit of Publicly
Available Sector Websites. Clin Ophthalmol. 2021;15:4029-4034

Machin H. Should Australia Export Corneas? Eye banks, exports and Australian Opinion: Exploring national utility of human corneal tissue
donation. University of Melbourne. August

Machin HM. Documenting the evolution of contemporary eye bank and corneal tissue services in Australia. Int J Eye Bank. 2019;2:7.

Machin H, Philippy B, Ross, C, Sutton G, Baird PN. Part 2: Defining surplus and waste in the pre- and post-COVID-19 era via Australian and
USA examples. Int J Eye Bank. 2020;8:3.

Martin D, Kelly R, Jones G, Machin H, Pollock G. Ethical Issues in Transitional Eye Banking. Cornea 2017; 36(2): 252-257.

Moffatt SL, Pollock GA. Creutzfeldt-Jakob disease: perceptions and realities of risk. Clin Exp Ophthalmol. 2006 Sep-Oct;34(7):635-6.

Appukuttan B, Ma Y, Stempel AJ, Ashander LM, Deliyanti D, Wilkinson-Berka JL, Smith JR. Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells. Clin Exp Ophthalmol 2018; 46: 652-660.

Ashander LM, Lie S, Ma Y, Rochet E, Washington JM, Furtado JM, Appukuttan B, Smith JR. Neutrophil activities in human ocular toxoplasmosis: an in vitro study with human cells. Invest Ophthalmol Vis Sci 2019; 60: 4652-4660.

Lie S, Rochet E, Segerdell E, Ma Y, Ashander LM, Shadford AM, Blenkinsop TA, Michael MZ, Appukuttan B, Wilmot B, Smith JR. Immunological molecular responses of human retinal pigment epithelial cells to infection with Toxoplasma gondii. Front Immunol 2019; 10: 708.

Lie S, Vieira BR, Arruda S, Simões M, Ashander LM, Furtado JM, Smith JR. Molecular basis of the retinal pigment epithelial changes that characterize the ocular lesion in toxoplasmosis. Microorganisms 2019; 7: 405. 

Lumsden A, Ma Y, Ashander LM, Stempel AJ, Keating D, Smith JR, Appukuttan B. ICAM-1-related long non-coding RNA: promoter analysis and expression in human retinal endothelial cells. BMC Res Notes 2018; 11: 285.

Merridew NL, Phagura RS, Anderson E, Cooley LA, Pollock GA, McEwan B, McCartney PJ, Trad MA. Successful Treatment of Mycobacterium chelonae Keratitis Within a Corneal Transplant Using Intrastromal Amikacin Injections-A Case Report Demonstrating the Fundamental Principles and Challenges of Infective Keratitis Management and Novel Therapeutic Approaches. Open Forum Infect Dis. 2019 Jul 22;6(8)

Pollock GA, Hamlyn L, Maguire SH, Stewart-Richardson PA, Hardie IR. Effects of four cryoprotectants in combination with two vehicle solutions on cultured vascular endothelial cells. Cryobiology. 1991 Oct;28(5):413-21.

Pollock GA, McKelvie PA, McCarty DJ, White JF, Mallari PL, Taylor HR. In vivo effects of fluoroquinolones on rabbit corneas. Clin Exp Ophthalmol. 2003 Dec;31(6):517-21.

Rochet E, Appukuttan B, Ma Y, Ashander LM, Smith JR. Expression of long non-coding RNA by human retinal Müller glial cells infected with clonal and exotic virulent Toxoplasma gondii. non-coding RNA 2019; 5: 48.

Ryan FJ, Carr JM, Furtado JM, Ma Y, Ashander LM, Simões M, Oliver GF, Granado GB, Dawson AC, Michael MZ, Appukuttan B, Lynn DJ, Smith JR. Zika virus infection of human iris pigment epithelial cells. Front Immunol 2021; 12:644153.

Patel HY, Ormonde S, Brookes NH, Moffatt L and McGhee CNJ. (2005). The indications and outcomes of paediatric corneal transplantation in New Zealand: 1991-2003. British Journal of Ophthalmology 89: 404-408. doi: 10.1136/bjo.2004.053116

Edwards M, Clover GM, Brookes NH, Pendergrast D, Chaulk J, McGhee CNJ. (2002). Indications for corneal transplantation in New Zealand: 1991-1999. Cornea 21(2): 152-5. doi: 10.1097/00003226-200203000-00004

Lu LM, Boyle AB, Niederer RL, Brookes NH, McGhee CN, Patel DV. (2019). Repeat corneal transplantation in Auckland, New Zealand: indications, visual outcomes and risk factors for repeat keratoplasty failure. Clinical and
Experimental Ophthalmology. 47(8):987-994. doi: 10.1111/ceo.13581.